Home Members Mario Valenti

Mario Valenti

Assistant Professor

Dermatology and venereal diseases

Assistant Professor

Education

2016 Degree in medicine and surgery, “Vita-Salute” San Raffaele University, Milan
2017-2021 Residency in Dermatology and Venereology, Humanitas University, Pieve Emanuele (Milan)
2021 Clinical and research fellowship at the dermatology department of “Zurich University Hospital”, with a particular focus on advanced skin cancers management (eg. immunotherapy, targeted therapies).

Academic honors, awards and prices

Selected for Euroderm Excellence congress, Rome, 2019
Poster prize on dermato-surgery at “ADOI national congress” 2021
Winner of the “WINTHER” research project on raster scan optical mesoscopy for therapeutic monitoring of skin and systemic disorders
Poster prize at ADOI national congress, 2022

Diagnosis and management of immune-mediated skin diseases, focusing on new therapeutic approaches with the newest biologics and small molecules (involved in phase II/III and IV clinical trials)
Raster scan optical mesoscopy for early diagnosis and therapeutic monitoring of skin diseases and systemic disorders (winner of the “WINTHER” research project in 2021)
Non-invasive diagnostic, follow up and medical treatment of skin tumors (involved in phase II/III clinical trials)
Dermato-surgery for both melanoma and non-melanoma skin cancers

Valenti M et al. Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population. J Dermatolog Treat. 2022 May;33(3):1638-1642. doi: 10.1080/09546634.2021.1886231.
Valenti M, Narcisi A et al. What Can IBD Specialists Learn from IL-23 Trials in Dermatology? J Crohns Colitis. 2022 May 11;16(Supplement_2):ii20-ii29. doi: 10.1093/ecco-jcc/jjac023.
Fiorillo G, Toso F, Cortese A, Piscazzi F, Bressan A, Bramanti S, Manara S, Narcisi A, Costanzo A, Valenti M. Cutaneous toxicity of CAR T-cell therapy: Case report of a bullous life-threatening reaction. J Eur Acad Dermatol Venereol. 2023 Jan 20. doi: 10.1111/jdv.18892.
Valenti M. et al. Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital. Int J Dermatol. 2021 Jul;60(7):860-863. doi: 10.1111/ijd.15501.
Valenti M et al. Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report. Dermatol Ther. 2022 Dec;35(12):e15952. doi: 10.1111/dth.15952.